Evidano home
Commentary on News

AI Qualitative Analysis Healthcare: HCV Access

Evidano8 min read

Healthcare researchers need to connect quantitative service data with the lived experiences behind delayed or incomplete care. The November 20, 2026 PLOS One study on Hepatitis C virus treatment access in Los Angeles County shows why AI qualitative analysis healthcare workflows can be valuable: researchers must compare reported barriers, interview themes, languages, treatment status, and structural conditions without losing participant context. This article explains what the study found, how its mixed-methods design worked, and how AI-assisted qualitative analysis can help public health and healthcare teams organize similar evidence. The source study is exploratory and does not establish causal relationships. Medical and public health teams should use AI analysis as research support, not as a diagnostic or treatment decision.

Key Takeaways

The PLOS One study, “Exploring barriers and facilitators to Hepatitis C virus treatment access in Los Angeles County”, published on November 20, 2026, found that HCV treatment access was shaped by personal, provider-related, insurance, language, transportation, and healthcare-system barriers.

The study shows that AI qualitative analysis healthcare teams can use should combine frequency patterns with thematic interpretation, subgroup comparison, and direct review of interview evidence.

  • From October 2024 through January 2025, Los Angeles County program data covered 344 case-residents, including 168 people who had been treated and 176 people who had not received treatment, according to the PLOS One study.
  • According to the PLOS One study, 54% of case-residents reported barriers, and among the 91 people reporting specific barriers, personal barriers represented 43%, provider-related barriers 31%, insurance barriers 13%, and inadequate medical access 13%.
  • The PLOS One study included 10 semi-structured interviews, with 7 untreated participants and 3 treated participants, conducted in English and Spanish between October 2024 and January 2025.
  • The study identified homelessness, incarceration, drug addiction, language barriers, cost, transportation, long provider wait times, limited HCV information, and difficulty navigating healthcare as important barriers.
  • The study identified motivation, family and community support, provider trust, adequate insurance, understanding treatment benefits, and reducing stigma as facilitators of HCV treatment access.

What the HCV Access Study Measured

The Los Angeles County study used a convergent parallel mixed-methods design to measure both how often HCV treatment barriers were reported and how participants experienced those barriers. The quantitative component analyzed de-identified program data from Project HCV Connect, while the qualitative component used thematic analysis of semi-structured interviews.

The PLOS One authors reported that case managers contacted 344 people with a reported HCV-positive test result between October 2024 and January 2025. The program collected information about demographics, insurance, treatment status, willingness to receive treatment, and reported barriers.

The research team conducted interviews with 10 participants, including 7 untreated participants and 3 treated participants. The interviews explored knowledge, attitudes, beliefs, stigma, insurance, health literacy, treatment journeys, and potential strategies for improving treatment linkage.

The study team used inductive coding and iterative comparison of transcripts, then met to compare codes and resolve disagreements. The researchers also analyzed treated and untreated participants separately to examine differences associated with treatment status.

The authors cautioned that the small qualitative sample and limited subgroup counts prevented inferential statistical analysis. The findings are therefore preliminary and locally focused, rather than representative of all people with HCV in Los Angeles County.

Findings Snapshot: AI Qualitative Analysis Healthcare Context

Date or periodMetricValueImplication for qualitative analysis
October 2024 to January 2025Los Angeles County case-residents contacted344A mixed-methods workflow must connect program-scale records with smaller interview samples, according to the PLOS One study.
October 2024 to January 2025Case-residents already treated168, or 49%Treatment status enables cross-segment comparison between treated and untreated experiences, according to the PLOS One study.
October 2024 to January 2025Case-residents not treated176Untreated narratives help explain why diagnosis does not always lead to treatment initiation, according to the PLOS One study.
October 2024 to January 2025Case-residents reporting barriers54%Barrier prevalence provides a quantitative frame for interpreting interview themes, according to the PLOS One study.
October 2024 to January 2025People reporting specific barriers91The study ranked personal barriers at 43%, provider barriers at 31%, insurance barriers at 13%, and inadequate medical access at 13%.
October 2024 to January 2025Qualitative interviews10 participantsInterview evidence added context about language, stigma, cost, support, provider trust, and system navigation, according to the PLOS One study.

What Healthcare Researchers Can Learn from the HCV Themes

Healthcare researchers should treat HCV access as a multi-level experience rather than a single patient-compliance problem. The PLOS One study connected personal circumstances, provider interactions, insurance conditions, and broader access limitations.

Language and communication were central qualitative themes. One untreated Spanish-speaking participant told the researchers, “Since I don’t speak 100% English... I didn’t understand anything, ” while describing how a Spanish-speaking primary care doctor later explained hepatitis C clearly.

The PLOS One study also found that limited information affected treatment engagement. An untreated Spanish-speaking participant said, “I hadn’t heard so much about [HCV at the time of my diagnosis], ” illustrating how diagnosis without understandable education can leave patients uncertain about treatment.

The study showed that readiness to receive care can coexist with system delays. One treated participant reported that it took two months to meet a specialist after a referral, while other participants described homelessness, incarceration, drug addiction, and long waits as interruptions to care.

The source authors recommended language support, patient navigation, care coordination, mobile clinics for people experiencing homelessness, treatment continuity after incarceration, and fewer insurance restrictions. AI-assisted analysis can help teams identify which barriers recur, which groups describe them most often, and which quotations explain the mechanisms behind the counts.

How Evidano Supports AI Qualitative Analysis Healthcare Teams

Problem: Researchers must synthesize interviews and program documents

Evidano is an AI-powered qualitative data analysis platform that helps researchers analyze interviews, open-ended survey responses, papers, reports, and other documents.

Evidano can support a mixed-methods workflow by organizing documents and generating thematic, content, frequency, and cross-segment analyses. Researchers can use these outputs to compare treated and untreated participants, English- and Spanish-language interviews, or patient-level and system-level barriers.

Teams can learn more about Evidano's research workflow on the Evidano features page.

Problem: Multilingual interviews can hide important access barriers

The Los Angeles County study conducted interviews in English and Spanish and identified language barriers as part of the treatment access problem.

Evidano supports transcription and translation workflows, including custom dictionaries that can help preserve domain-specific terminology. Researchers should validate translated text and interpretations against the original recordings or transcripts, especially when language and cultural meaning are central to the research question.

Evidano's translation workflow is relevant for teams analyzing multilingual healthcare interviews.

Problem: Researchers need traceable answers across a large evidence set

The PLOS One study compared quantitative barrier categories with qualitative themes, which requires researchers to move repeatedly between counts, participant segments, and source passages.

Evidano's AI chat over documents and analyses can help research teams ask focused questions about recurring barriers, facilitators, subgroup differences, and supporting excerpts. Human researchers remain responsible for checking the source context, coding decisions, and ethical interpretation.

Problem: Stakeholders need understandable outputs for action

The PLOS One authors translated their findings into possible interventions involving language support, navigation, mobile clinics, care coordination, and insurance policy.

Evidano can help teams present qualitative patterns through visualizations such as word clouds, co-occurrence networks, and hierarchical codes and subcodes. These outputs can make relationships between barriers, facilitators, participant segments, and proposed interventions easier to review.

FAQ: AI Qualitative Analysis Healthcare and HCV Access

What did the 2026 Los Angeles County HCV study find?

The 2026 PLOS One study found that 54% of 344 contacted case-residents reported barriers to HCV treatment access.

Among 91 people who reported specific barriers, personal barriers were most common at 43%, followed by provider-related barriers at 31%, insurance barriers at 13%, and inadequate medical access at 13%. The study's interviews added context about language, cost, transportation, stigma, housing instability, and healthcare navigation.

Why combine quantitative and qualitative analysis in healthcare research?

Mixed-methods healthcare research combines prevalence information with explanations of how people experience barriers.

The Los Angeles County study used program data to show how often barriers occurred and interviews to explain why language, provider communication, cost, wait times, and social conditions affected treatment decisions.

How can AI help analyze healthcare interviews?

AI can help healthcare researchers organize transcripts, identify themes, count recurring concepts, compare participant segments, and retrieve supporting passages.

AI outputs do not replace researcher judgment, participant protections, or methodological review. Researchers should verify quotations, preserve context, inspect subgroup limitations, and avoid treating exploratory themes as clinical conclusions.

What were the main facilitators of HCV treatment access?

The main facilitators identified by the PLOS One study were personal motivation, family and community support, trust in providers, adequate insurance, understanding treatment benefits, and the desire to reduce stigma.

These facilitators suggest that outreach and navigation programs should pair understandable education with practical support and reliable care coordination.

Can AI qualitative analysis replace a healthcare research team?

AI qualitative analysis cannot replace a healthcare research team because researchers must interpret context, assess bias, protect confidentiality, and determine whether findings support an intervention.

AI is better used as an analysis assistant that accelerates document review and comparison while trained researchers retain responsibility for coding quality, ethics, and reporting.

Conclusion and Next Steps for HCV Qualitative Research

The November 20, 2026 PLOS One study demonstrates that HCV treatment access is shaped by interacting personal, linguistic, economic, provider, and system-level conditions. AI qualitative analysis healthcare teams can use should connect quantitative frequencies with carefully reviewed themes, subgroup comparisons, and participant quotations. Evidano helps researchers organize these inputs and turn complex qualitative evidence into clearer, auditable findings. Healthcare and public health teams can try Evidano for free to begin analyzing interviews, reports, and open-ended research data.

Topics

  • AI qualitative analysis healthcare
  • AI thematic analysis healthcare
  • HCV treatment access barriers
  • qualitative healthcare research
  • mixed-methods health research

Keep reading

Browse all articles